Anderson I M, Nutt D J, Deakin J F
University of Manchester Department of Psychiatry, University of Manchester, UK.
J Psychopharmacol. 2000 Mar;14(1):3-20. doi: 10.1177/026988110001400101.
A revision of the British Association for Psychopharmacology guidelines for treating depressive disorders with antidepressants was undertaken in order to specify the scope and target of the guidelines and to update the recommendations based explicitly on the available evidence. A consensus meeting, involving experts in depressive disorders and their treatment, reviewed key areas and considered the strength of evidence and clinical implications. The guidelines were drawn up after extensive feedback from participants and interested parties. A literature review is given which identifies the quality of evidence followed by recommendations, the strength of which are based on the level of evidence. The guidelines cover the nature and detection of depressive disorders, acute treatment with antidepressant drugs, choice of drug versus alternative treatment, practical issues in prescribing, management when initial treatment fails, continuation treatment, maintenance treatment to prevent recurrence and stopping treatment.
英国精神药理学会对使用抗抑郁药治疗抑郁症的指南进行了修订,目的是明确指南的范围和目标,并根据现有证据明确更新建议。一次由抑郁症及其治疗领域专家参与的共识会议,对关键领域进行了审查,并考量了证据强度和临床意义。指南在参与者和相关各方的广泛反馈后制定而成。文中给出了一份文献综述,确定了证据质量,随后是基于证据水平的建议及其强度。这些指南涵盖了抑郁症的性质与检测、抗抑郁药的急性治疗、药物与替代治疗的选择、处方中的实际问题、初始治疗失败时的处理、持续治疗、预防复发的维持治疗以及停药治疗。